Fortress Biotech, Inc. (FBIO:NASDAQ) closed at $1.90 on October 14, 2026, down 2.56% on the day. The stock trades 58.1% below its 52-week high of $4.53 and 1.1% above its 52-week low of $1.88. Over the past year, it lost 32.6%. Fortress Biotech, Inc. is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -9.95% | -23.69% | -43.45% | -18.10% | -32.62% |
In 252 trading sessions since October 14, 2025, FBIO closed higher on 112 days (44%). Its best day was December 15, 2025 (+13.31%) and its worst was January 14, 2026 (-15.90%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 1 time.
Coronado Biosciences, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. Its principal pharmaceutical product candidates in clinical development include Trichuris suis ova or...
Find more stocks like FBIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.